☆ 4.7 Article

Amino Acid PET in Neurooncology

JOURNAL OF NUCLEAR MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas

Michael M. Wollring et al.

Summary: PET imaging using radiolabeled amino acids combined with MRI is a valuable diagnostic tool in managing brain tumor patients. This review provides an overview of PET studies in glioma patients with IDH mutation, which typically do not show contrast enhancement on MRI. The review focuses on the role of amino acid PET in differential diagnosis, treatment planning, and response assessment in patients with IDH-mutant gliomas.

JOURNAL OF NEURO-ONCOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis

Timo Schluermann et al.

Summary: This study aimed to summarize the diagnostic utility of amino acid PET in recurrent brain metastases. The analysis of 12 studies with a total of 547 lesions in 397 patients showed that amino acid PET had good accuracy in the differential diagnosis of recurrent brain metastases, with a specificity of 84%, suggesting it can reduce the need for invasive procedures and overtreatment.

JOURNAL OF NUCLEAR MEDICINE (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET

Ali Nabavizadeh et al.

Summary: 18F-fluciclovine PET combined with multiparametric MRI can accurately differentiate between pseudoprogression and tumor progression, which is of great value in neurooncology, and this method is widely available.

JOURNAL OF NUCLEAR MEDICINE (2023)

添加到收藏夹

Article Oncology

Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET

Michael M. Wollring et al.

Summary: This study evaluated the use of FET PET and MRI for early response assessment in recurrent glioma patients treated with lomustine-based chemotherapy. The results suggest that FET PET provides complementary information to RANO criteria for response evaluation early after treatment initiation.

NEURO-ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Sequential and Hybrid PET/MRI Acquisition in Follow-Up Examination of Glioblastoma Show Similar Diagnostic Performance

Julian Ziegenfeuter et al.

Summary: Reliable differentiation between true tumor progression and treatment-related changes in glioma patients is challenging. This study investigated the diagnostic performance of simultaneous and sequential acquisition of PET and MRI in 38 glioblastoma patients. The results showed no significant difference in global and local image metrics, as well as the diagnostic performance, between the two acquisition methods. This suggests that sequential acquisition is clinically and scientifically acceptable, supporting further research on multi-parametric models for personalized decision-making in neuro-oncology.

CANCERS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Differentiating high-grade glioma progression from treatment-related changes with dynamic [18F]FDOPA PET: a multicentric study

Laura Rozenblum et al.

Summary: This study assesses the diagnostic value of static and dynamic [F-18]FDOPA PET acquisitions in distinguishing between high-grade glioma recurrence and treatment-related changes. The results show that TBRmean parameter of [F-18]FDOPA PET has good diagnostic ability in the overall population, while curve slope is significantly different only in IDH-mutant HGGs. MTV and curve slope were identified as independent predictors of progression-free survival and overall survival.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction

Giuseppe Lombardi et al.

Summary: The aim of this study was to evaluate the ability of [F-18]FET and ADC metrics to identify treatment response and predict overall survival in recurrent glioblastoma patients treated with regorafenib. The results showed that these two metrics performed at least as well as RANO criteria in predicting overall survival, and in some cases even better.

BRITISH JOURNAL OF RADIOLOGY (2022)

添加到收藏夹

Article Oncology

Safety and Efficacy of Irradiation Boost Based on 18F-FET-PET in Patients with Newly Diagnosed Glioblastoma

Maciej Harat et al.

Summary: This study evaluated the safety and efficacy of simultaneous integrated boost (SIB) planned using dual FET-PET for postoperative GBM treatment. The results showed that SIB with dual FET-PET improved survival outcomes, but there was a risk of radiation necrosis.

CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Arnoldo Piccardo et al.

Summary: This document provides guidelines for the use of [F-18]FDG and radiolabelled amino acid PET imaging in pediatric patients with brain gliomas. The recommendations are consensus opinions of experienced leaders in the field and further research is needed to support evidence-based recommendations.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of 18F-FET PET/MRI on Clinical Management of Brain Tumor Patients

Cornelia Brendle et al.

Summary: Multiparametric PET/MRI with F-18-FET enables the simultaneous assessment of brain tumor characteristics, and has a significant impact on diagnosis and clinical management. It can accurately identify malignancy and distinguish tumor progression from therapy-related imaging alterations, providing valuable information for treatment decisions.

JOURNAL OF NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy

Jurij Rosen et al.

Summary: This study compared the effectiveness and cost effectiveness of F-18-FET PET with conventional MRI for identifying early responders to adjuvant temozolomide chemotherapy. The results showed that F-18-FET PET had a higher rate of correctly identifying responders and was cost-effective compared to MRI.

JOURNAL OF NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Oncology

Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group

Norbert Galldiks et al.

Summary: Many studies on innovative PET tracers in brain tumor patients have been published recently, showing promising initial results. The Response Assessment in Neuro-Oncology (RANO) PET working group provides an overview of the literature on these novel investigational PET tracers and discusses new indications of established PET tracers. Based on preliminary findings, further evaluation of these novel investigational PET tracers is recommended due to their potential in tumor delineation and therapy monitoring.

NEURO-ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Julich Experience

Alexander Heinzel et al.

Summary: PET imaging using O-(2-[F-18]fluoroethyl)-L-tyrosine (FET) as a tracer has become essential for diagnosing brain tumors, with increasing demand seen for differentiating tumor progress and treatment-related changes. Referring physicians rate FET PET highly for diagnosing recurrent gliomas and brain metastases.

CANCERS (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnostic Value of 18F-FACBC PET/MRI in Brain Metastases

Silje Kjarrnes Oen et al.

Summary: The study aimed to evaluate if combined F-18-FACBC PET/MRI could provide additional diagnostic information compared to MRI alone in brain metastases. The results showed that F-18-FACBC PET/MRI did not improve the detection of brain metastases compared to MRI, but it might detect tumor tissue beyond the contrast enhancement seen on MRI.

CLINICAL NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment

Tomohiro Yamaki et al.

Summary: The study investigated the role of 11C-METPET in differentiating brain tumors from non-neoplastic lesions. The use of optimal cutoff values showed high specificity, indicating a high likelihood of brain tumor.

CLINICAL IMAGING (2022)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value A Multicentric 11C-Methionine and 18F-FDOPA PET Experience

Timothee Zaragori et al.

Summary: In newly diagnosed glioma patients, photopenic defects were identified using C-11-MET and F-18-FDOPA PET tracers, with lower tumor-to-background ratio compared to isometabolic gliomas. While photopenic gliomas showed no difference in progression-free survival in the whole population, they had shorter progression-free survival in the subgroup of World Health Organization grade II IDH-mutant astrocytomas.

CLINICAL NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences

Norbert Galldiks et al.

Summary: The study showed that F-18-FET PET is valuable for treatment monitoring in patients with brain metastasis undergoing ICI or TT, assisting in distinguishing between metastasis relapse and treatment-related changes, and providing valuable information in assessing metabolic responses to ICI or TT.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Oncology

Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET

Francesco Cicone et al.

Summary: In this study, the long-term metabolic evolution of radiation necrosis (RN) in brain metastases patients following stereotactic radiosurgery (SRS) was characterized using sequential PET/CT imaging with F-DOPA. It was found that F-DOPA uptake parameters increased over time in lesions with local progression (LP) while remaining stable in RN lesions. F-DOPA PET showed high diagnostic accuracy for assessing the long-term evolution of brain metastases following SRS.

NEURO-ONCOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

Eike Steidl et al.

Summary: The retrospective analysis evaluated the diagnostic value of consecutive PWI and [F-18]FET PET, showing that the combination of both methods can improve overall accuracy. Under specific conditions, PWI outperformed [F-18]FET PET for certain tumors. These results emphasize the importance of sequential use of PWI and [F-18]FET PET in clinical diagnosis.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Oncology

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller et al.

Summary: The European Association of Neuro-Oncology (EANO) has released guidelines for the diagnosis, treatment, and follow-up of adult patients with diffuse gliomas, incorporating major changes in diagnostic algorithms based on the 2016 update of the WHO Classification of Tumors of the Central Nervous System, as well as evidence from recent large clinical trials.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of therapy response to Regorafenib by 18F-DOPA-PET/CT in patients with recurrent high-grade gliomas: a case series

Eugenio Di Giorgio et al.

Summary: The study found that F-18-DOPA PET/CT enables an early and reliable assessment of metabolic response to REG treatment, with a major advantage in patients where MR cannot differentiate between non-response and tumor pseudo-progression.

CLINICAL AND TRANSLATIONAL IMAGING (2021)

添加到收藏夹

Article Oncology

Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET

Jan-Michael Werner et al.

Summary: The study evaluated the value of FET-PET parameters in diagnosing pseudoprogression related to lomustine-temozolomide chemoradiation, finding that TBRmean had the highest accuracy in identifying pseudoprogression. Furthermore, integrating relative changes of TBRmean improved accuracy, and combining static and dynamic parameters increased specificity to 100%.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma

Nadia Nicole Laack et al.

Summary: The study aimed to evaluate the safety and efficacy of biologic-guided, dose-escalated radiation therapy using F-18-DOPA PET in patients with glioblastoma. The results showed that this approach significantly improved progression-free survival in MGMT unmethylated glioblastoma patients and significantly improved overall survival in MGMT methylated patients. Further investigation of this treatment approach is warranted.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Oncology

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Hussein A. Tawbi et al.

Summary: The combination of nivolumab and ipilimumab shows durable clinical benefit for asymptomatic patients with melanoma brain metastases, but has limited activity in patients with neurological symptoms and/or requiring corticosteroids.

NEURO-ONCOLOGY (2021)

添加到收藏夹

Article Oncology

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

E. Le Rhun et al.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy

Garry Ceccon et al.

Summary: Changes in F-18-FET PET parameters were found to be helpful for early identification of responders to adjuvant TMZ therapy, predicting prolonged progression-free survival (PFS) and overall survival (OS). These changes were independent of other strong prognostic factors, suggesting their potential clinical utility in glioma patients.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Oncology

Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study

Niels Verburg et al.

NEURO-ONCOLOGY (2020)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas

Domenico Albano et al.

ANNALS OF NUCLEAR MEDICINE (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas

S. Schoen et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

添加到收藏夹

Letter Clinical Neurology

O-(2-(18F) fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma

Milena I. Mihovilovic et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity

Kenney Roy Roodakker et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

添加到收藏夹

Review Oncology

Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients

Philipp Lohmann et al.

CANCERS (2019)

添加到收藏夹

Article Oncology

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients

Norbert Galldiks et al.

NEURO-ONCOLOGY (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI

Jan-Michael Werner et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma

Trond V. Bogsrud et al.

CLINICAL NUCLEAR MEDICINE (2019)

添加到收藏夹

Article Oncology

Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)

Asma Bashir et al.

NEURO-ONCOLOGY (2019)

添加到收藏夹

Review Oncology

18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis

Riccardo Laudicella et al.

CANCERS (2019)

添加到收藏夹

Article Oncology

Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2[18F]fluoroethyl)-L-tyrosine PET

Diana S. Y. Abdulla et al.

CLINICAL LUNG CANCER (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma

Philipp Lohmann et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Ian Law et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

添加到收藏夹

Article Oncology

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Review Oncology

PET imaging in patients with brain metastasis-report of the RANO/PET group

Norbert Galldiks et al.

NEURO-ONCOLOGY (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine

Norbert Galldiks et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI

Thomas Pyka et al.

EUROPEAN JOURNAL OF RADIOLOGY (2018)

添加到收藏夹

Article Oncology

18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy

Bogdana Suchorska et al.

JOURNAL OF NEURO-ONCOLOGY (2018)

添加到收藏夹

Article Oncology

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

Yi-Long Wu et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Hussein A. Tawbi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Conventional and advanced magnetic resonance imaging in patients with high-grade glioma

Whitney B. Pope et al.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

添加到收藏夹

Editorial Material Oncology

Pseudoprogression: fact or wishful thinking in neuro-oncology?

David A. Reardon et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Review Clinical Neurology

New developments in brain metastases

Anna S. Berghoff et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis

Marcus Unterrainerl et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-L-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic

Markus Hutterer et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

添加到收藏夹

Article Oncology

Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy

Garry Ceccon et al.

NEURO-ONCOLOGY (2017)

添加到收藏夹

Review Clinical Neurology

Advances in neuro-oncology imaging

Karl-Josef Langen et al.

NATURE REVIEWS NEUROLOGY (2017)

添加到收藏夹

Article Oncology

O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis

Alexander Heinzel et al.

NEURO-ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Comparison of Gadolinium-enhanced MRI and 18FDG PET/PET-CT for the diagnosis of brain metastases in lung cancer patients: A meta-analysis of 5 prospective studies

Ye Li et al.

ONCOTARGET (2017)

添加到收藏夹

Review Neuroimaging

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy

Norbert Galldiks et al.

NEUROIMAGE-CLINICAL (2017)

添加到收藏夹

Article Oncology

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

Ulrich Roelcke et al.

NEURO-ONCOLOGY (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Spectrum and Pitfalls of 11C-Methionine Positron Emission Tomography in a Series of Patients with Intracranial Lesions

Kimiteru Ito et al.

KOREAN JOURNAL OF RADIOLOGY (2016)

添加到收藏夹

Editorial Material Clinical Neurology

NEURO-ONCOLOGY Amino acid PET for brain tumours - ready for the clinic?

Karl-Josef Langen et al.

NATURE REVIEWS NEUROLOGY (2016)

添加到收藏夹

Article Oncology

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

Nathalie L. Albert et al.

NEURO-ONCOLOGY (2016)

添加到收藏夹

Letter Oncology

Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases

Sied Kebir et al.

NEURO-ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET-PET overcome diagnostic uncertainties?

Alexander Romagna et al.

RADIATION ONCOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?

Norbert Galldiks et al.

FRONTIERS IN NEUROLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers

Caroline Papin-Michault et al.

PLOS ONE (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI

Francesco Cicone et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

添加到收藏夹

Article Oncology

The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma

Norbert Galldiks et al.

NEURO-ONCOLOGY (2015)

添加到收藏夹

Article Clinical Neurology

Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM

Bogdana Suchorska et al.

NEUROLOGY (2015)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET

Norbert Galldiks et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery

Francesco Cicone et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

添加到收藏夹

Article Oncology

Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma

Per Munck af Rosenschold et al.

NEURO-ONCOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment

Ryogo Minamimoto et al.

PLOS ONE (2015)

添加到收藏夹

Article Oncology

Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy

Johannes Schwarzenberg et al.

CLINICAL CANCER RESEARCH (2014)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?

Quentin Sala et al.

CLINICAL NUCLEAR MEDICINE (2014)

添加到收藏夹

Letter Oncology

Letter to the Editor: The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline [J Neurooncol 2014; 118:435-460]

Karl-Josef Langen et al.

JOURNAL OF NEURO-ONCOLOGY (2014)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

F-18-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment

Karlo J. Lizarraga et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

添加到收藏夹

Article Oncology

Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients

Ken Herrmann et al.

NEURO-ONCOLOGY (2014)

添加到收藏夹

Article Clinical Neurology

Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis

T. Nihashi et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2013)

添加到收藏夹

Article Neurosciences

Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and L-[methyl-11C]methionine in human glioma cell lines

Masahiro Ono et al.

BRAIN RESEARCH (2013)

添加到收藏夹

Article Clinical Neurology

Bevacizumab as salvage therapy for progressive brain stem gliomas

T. Reithmeier et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Response assessment of bevacizumab in patients with recurrent malignant glioma using [F-18]Fluoroethyl-l-tyrosine PET in comparison to MRI

Norbert Galldiks et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)

添加到收藏夹

Article Oncology

Multimodal Magnetic Resonance Imaging and 18F-L-Dihydroxyphenylalanine Positron Emission Tomography in Early Characterization of Pseudoresponse and Nonenhancing Tumor Progression in a Pediatric Patient With Malignant Transformation of Ganglioglioma Treated With Bevacizumab

Giovanni Morana et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Article Oncology

The role of LAT1 in 18F-DOPA uptake in malignant gliomas

Ryan S. Youland et al.

JOURNAL OF NEURO-ONCOLOGY (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma

Marion Rapp et al.

JOURNAL OF NUCLEAR MEDICINE (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The Use of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis

Alexander Heinzel et al.

JOURNAL OF NUCLEAR MEDICINE (2013)

添加到收藏夹

Article Oncology

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot et al.

LANCET ONCOLOGY (2013)

添加到收藏夹

Letter Oncology

Reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma by Hutterer et al.

Karl-Josef Langen et al.

NEURO-ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study

Deanna H. Pafundi et al.

NEURO-ONCOLOGY (2013)

添加到收藏夹

Article Oncology

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma

Markus Hutterer et al.

NEURO-ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Invasion patterns in brain metastases of solid cancers

Anna S. Berghoff et al.

NEURO-ONCOLOGY (2013)

添加到收藏夹

Article Biochemical Research Methods

Earlier Diagnosis of Progressive Disease during Bevacizumab Treatment Using O-(2-18F-Fluorethyl)-L-Tyrosine Positron Emission Tomography in Comparison with Magnetic Resonance Imaging

Norbert Galldiks et al.

MOLECULAR IMAGING (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas

Alexander Heinzel et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

Nathalie L. Jansen et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Cost-Effectiveness Analysis of Amino Acid PET-Guided Surgery for Supratentorial High-Grade Gliomas

Alexander Heinzel et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Transport of 3-Fluoro-L-α-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET

Pattama Wiriyasermkul et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI

Norbert Galldiks et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis

Norbert Galldiks et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis

Vincent Dunet et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

添加到收藏夹

Article Oncology

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V. Long et al.

LANCET ONCOLOGY (2012)

添加到收藏夹

Article Oncology

Discrepant MR and [18F] Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure

Norbert Galldiks et al.

CASE REPORTS IN ONCOLOGY (2012)

添加到收藏夹

Review Clinical Neurology

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

L. C. Hygino da Cruz et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2011)

添加到收藏夹

Editorial Material Oncology

Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions

Manmeet S. Ahluwalia et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2011)

添加到收藏夹

Article Oncology

PROGNOSTIC VALUE OF EARLY [18F]FLUOROETHYLTYROSINE POSITRON EMISSION TOMOGRAPHY AFTER RADIOCHEMOTHERAPY IN GLIOBLASTOMA MULTIFORME

Marc D. Piroth et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma

Markus Hutterer et al.

JOURNAL OF NUCLEAR MEDICINE (2011)

添加到收藏夹

Article Oncology

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis

Giuseppe Minniti et al.

RADIATION ONCOLOGY (2011)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Volumetry of [C-11]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme

Norbert Galldiks et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?

Robert Pichler et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)

添加到收藏夹

Article Oncology

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas

Shuichi Okubo et al.

JOURNAL OF NEURO-ONCOLOGY (2010)

添加到收藏夹

Review Clinical Neurology

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

Frederic G. Dhermain et al.

LANCET NEUROLOGY (2010)

添加到收藏夹

Article Biochemical Research Methods

Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma

Norbert Galldiks et al.

MOLECULAR IMAGING (2010)

添加到收藏夹

Article Oncology

Early metabolic responses in temozolomide treated low-grade glioma patients

Matthias Wyss et al.

JOURNAL OF NEURO-ONCOLOGY (2009)

添加到收藏夹

Review Oncology

New advances that enable identification of glioblastoma recurrence

Isaac Yang et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy

Yuzo Terakawa et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

添加到收藏夹

Review Oncology

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

Dieto Brandsma et al.

LANCET ONCOLOGY (2008)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

C-11-L-methionine positron emission tomography in the clinical management of cerebral gliomas

Tarun Singhal et al.

MOLECULAR IMAGING AND BIOLOGY (2008)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses

Daumar Salber et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

添加到收藏夹

Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas

N Galldiks et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

O-(2-[18F]fluoroethyl)-L-tyrosine:: uptake mechanisms and clinical applications

KJ Langen et al.

NUCLEAR MEDICINE AND BIOLOGY (2006)

添加到收藏夹

Article Clinical Neurology

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

D Pauleit et al.

BRAIN (2005)

添加到收藏夹

Article Oncology

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography:: Local comparison with stereotactic histopathology

LW Kracht et al.

CLINICAL CANCER RESEARCH (2004)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Brain tumour imaging with PET:: a comparison between [18F]fluorodopa and [11C]methionine

A Becherer et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas

KJ Langen et al.

NUCLEAR MEDICINE AND BIOLOGY (2003)

添加到收藏夹

Article Clinical Neurology

Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET

K Herholz et al.

JOURNAL OF NEUROIMAGING (2003)

添加到收藏夹

Article Clinical Neurology

Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers

DM Long et al.

NEUROSURGERY (2003)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment

AJ Kumar et al.

RADIOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.